QQ客服 官方微博 反馈留言

	Survival outcomes of the NeoALTTO study (BIG 1-06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer
	Huober, Jens; Holmes, Eileen; Baselga, Jose; de Azambuja, Evandro; Untch, Michael; Fumagalli, Debora; Sarp, Severine; Lang, Istvan; Smith, Ian; Boyle, Frances
	2019
卷号	118页码:169-177
关键词	Breast cancer HER2 positive Neoadjuvant
ISSN号	0959-8049
DOI	10.1016/j.ejca.2019.04.038
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6337150
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Huober, Jens,Holmes, Eileen,Baselga, Jose,et al. Survival outcomes of the NeoALTTO study (BIG 1-06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer[J],2019,118:169-177.
APA	Huober, Jens.,Holmes, Eileen.,Baselga, Jose.,de Azambuja, Evandro.,Untch, Michael.,...&Di Cosimo, Serena.(2019).Survival outcomes of the NeoALTTO study (BIG 1-06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer.,118,169-177.
MLA	Huober, Jens,et al."Survival outcomes of the NeoALTTO study (BIG 1-06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer".118(2019):169-177.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。